Why Roche's $1.8 Billion Acquisition of GenMark Is a Smart Move

Healthcare giant Roche Holding (OTC:RHHBY) recently announced plans to acquire GenMark Diagnostics (NASDAQ:GNMK) in a deal valued at around $1.8 billion. The news sent GenMark's shares soaring close to 30%. In this Motley Fool Live video, recorded on March 17, Motley Fool contributors Keith Speights and Brian Orelli talk about why this acquisition is a smart move for Roche.